Russell K Pachynski, MD

Medical oncologist

Urologic specialist, Genitourinary specialist

Urologic Cancer Program

  • 875 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
Learn More About the Clinic Getting Here Make An Appointment

Radiation Oncology

  • 875 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Fellowship: Stanford University - CAPS (2009) CA

Residency: Stanford University - CAPS (2005) CA

Medical Education: Univ Of Ws Sch Of Med-Madison (2003) WI

Board Certification: Internal Medicine, American Board of Internal Medicine (2007)

Honors & Awards

Pilot Award, Stanford Translational Medicine Program (TRAM) (2012)

Fellowship Award, California Breast Cancer Research Program (2009-2010)

ASCO Young Investigator Award, American Society of Clinical Oncology (2009)

ASCO/AACR Workshop: Methods in Clinical Cancer Research, American Society of Clinical Oncology (2009)

NCCN Fellows Recognition Program, National Comprehensive Cancer Network (2007)

American Medical Association Seed Grant Award, American Medical Association (2002)

Howard Hughes Medical Institute Continuing Fellowship Award, Howard Hughes Medical Institute (2002)

Temple University Minority Research Trainee Forum Research Award, Temple University (2001-2)

UCSF Outstanding Performance Award, University of California, San Francisco (1996-8)

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Hospital & Clinics patient, you have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

The chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor defenses
Pachynski, R. K., Zabel, B. A., Kohrt, H. E., Tejeda, N. M., Monnier, J., & Butcher, E. C. (2012). The chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor defenses. JOURNAL OF EXPERIMENTAL MEDICINE, 209(8), 1427-1435.

Plasmacytoid Dendritic Cells Transport Peripheral Antigens to the Thymus to Promote Central Tolerance
Hadeiba, H., Lahl, K., Edalati, A., Oderup, C., Habtezion, A., & Butcher, E. C. (2012). Plasmacytoid Dendritic Cells Transport Peripheral Antigens to the Thymus to Promote Central Tolerance. IMMUNITY, 36(3), 438-450.

Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy
Chao, M. P., Tang, C., Pachynski, R. K., Chin, R., Majeti, R., & Weissman, I. L. (2011). Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy. BLOOD, 118(18), 4890-4901.

CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies
Kohrt, H. E., Houot, R., Goldstein, M. J., Weiskopf, K., Alizadeh, A. A., & Levy, R. (2011). CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies. BLOOD, 117(8), 2423-2432.

Prostate specific antigen doubling time (PSADT) in patients with hormone refractory prostate cancer (HRPC) undergoing docetaxel chemotherapy as a predictor of overall survival.
Pachynski RK, King C, & Srinivas S. (2007). Prostate specific antigen doubling time (PSADT) in patients with hormone refractory prostate cancer (HRPC) undergoing docetaxel chemotherapy as a predictor of overall survival. Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings, 25(18s).

Redirecting migration of T cells to chemokine secreted from tumors by genetic modification with CXCR2
Kershaw, M. H., Wang, G., Westwood, J. A., Pachynski, R. K., Tiffany, H. L., & Hwu, P. (2002). Redirecting migration of T cells to chemokine secreted from tumors by genetic modification with CXCR2. HUMAN GENE THERAPY, 13(16), 1971-1980.

Secondary lymphoid-tissue chemokine (SLC) stimulates integrin alpha(4)beta(7)-mediated adhesion of lymphocytes to mucosal addressin cell adhesion molecule-1 (MAdCAM-1) under flow
Pachynski, R. K., Wu, S. W., Gunn, M. D., & Erle, D. J. (1998). Secondary lymphoid-tissue chemokine (SLC) stimulates integrin alpha(4)beta(7)-mediated adhesion of lymphocytes to mucosal addressin cell adhesion molecule-1 (MAdCAM-1) under flow. JOURNAL OF IMMUNOLOGY, 161(2), 952-956.

Presentation of integrins on leukocyte microvilli: A role for the extracellular domain in determining membrane localization
Abitorabi, M. A., Pachynski, R. K., Ferrando, R. E., Tidswell, M., & Erle, D. J. (1997). Presentation of integrins on leukocyte microvilli: A role for the extracellular domain in determining membrane localization. JOURNAL OF CELL BIOLOGY, 139(2), 563-571.

Structure-function analysis of the integrin beta(7) subunit - Identification of domains involved in adhesion to MAdCAM-1
Tidswell, M., Pachynski, R., Wu, S. W., Qiu, S. Q., Dunham, E., & Erle, D. J. (1997). Structure-function analysis of the integrin beta(7) subunit - Identification of domains involved in adhesion to MAdCAM-1. JOURNAL OF IMMUNOLOGY, 159(3), 1497-1505.